Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Atropine Sulphate IP 1% w/v + Stabilized Oxychloro complex 0.005% w/v
Dosage Form : Eye Drops
Packaging Type : Dropper
Packaging : 5ml
Price : ₹1/-
Aeropine Eye Drop contains Atropine Sulphate 1% w/v, the most powerful anticholinergic agent used in ophthalmology. This concentration is typically reserved for obtaining maximal cycloplegia (paralysis of accommodation) necessary for accurate refractive assessment, particularly in children, and for the strong, sustained mydriasis required in treating severe uveitis (inflammation of the middle layer of the eye).
Mechanism and Impact:Atropine blocks muscarinic receptors, causing both prolonged dilation of the pupil (mydriasis) and complete relaxation of the eye's focusing muscle (cycloplegia). The crucial distinction of this formulation is the inclusion of Stabilized Oxychloro Complex (SOC) 0.005% w/v. SOC is a modern, oxidizing preservative that is less irritating to the ocular surface than traditional agents like Benzalkonium Chloride (BAK) because it rapidly dissipates into water and oxygen upon contact with the eye. This combination delivers clinical potency with improved patient comfort.
Key Therapeutic Uses:
Cycloplegic Refraction: The gold standard for determining true refractive error, especially in children with large accommodative power or strabismus.
Uveitis/Iritis Treatment: Reduces pain, stabilizes the blood-aqueous barrier, and prevents or breaks down synechiae (adhesions) between the iris and lens.
We offer an exclusive PCD Pharma Franchise opportunity for Aeropine Eye Drop, tapping into the consistent, specialized demand for potent cycloplegic eye drops.
Common side effects include frequent urination, dizziness, dehydration, low potassium levels, muscle cramps, weakness, and fatigue. Rare but serious effects may include low blood pressure, kidney dysfunction, or hearing disturbances.
Torslide 5 Tablet is indicated for the management of mild edema due to heart failure, kidney disease, or liver disorders, as well as for controlling mild to moderate hypertension (high blood pressure).
Use this medication only under medical supervision. Regular monitoring of blood pressure, kidney function, and electrolytes is essential. Patients with severe dehydration, kidney impairment, or electrolyte imbalances should consult their doctor before use.
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and store in its original packaging.
Composition : Moxifloxacin HCL I.P. 0.5% w/v + Ketorolac Tromethsmine I.P. 5% w/v Eye Drop
Composition : Loteprednol etabonate (0.5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Torsemide 20 mg Tablet
Composition : Torsemide 40mg Tablet
Composition : Torsemide (10mg/ml) Injection
Composition : Torsemide 5 mg + Spironolactone 50 mg Tablet
Composition : Torsemide 20 mg + Spironolactone 50 mg Tablet
Composition : TORSEMIDE 10 MG + SPIRONOLACTONE 25 MG
Composition : Torsemide 10mg + Spironolactone 50mg Tablets
Composition : Chlorthalidone 6.25mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation